-
1
-
-
0026696807
-
Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients
-
Bruderer, U., S. J. Cryz, Jr., U. B. Schaad, M. Deusinger, J. U. Que, and A. B. Lang. 1992. Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. J. Infect. Dis. 166:344-349.
-
(1992)
J. Infect. Dis.
, vol.166
, pp. 344-349
-
-
Bruderer, U.1
Cryz Jr., S.J.2
Schaad, U.B.3
Deusinger, M.4
Que, J.U.5
Lang, A.B.6
-
3
-
-
0029863296
-
Ventilator-associated pneumonia due to Pseudomonas aeruginosa
-
Crouch Brewer, S., R. G. Wunderink, C. B. Jones, and K. V. Leeper, Jr. 1996. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 109:1019-1029.
-
(1996)
Chest
, vol.109
, pp. 1019-1029
-
-
Crouch Brewer, S.1
Wunderink, R.G.2
Jones, C.B.3
Leeper Jr., K.V.4
-
4
-
-
0020658136
-
Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide
-
Cryz, S. J., Jr., E. Furer, and R. Germanier. 1983. Protection against Pseudomonas aeruginosa infection in a murine burn wound sepsis model by passive transfer of antitoxin A, antielastase, and antilipopolysaccharide. Infect. Immun. 39:1072-1079.
-
(1983)
Infect. Immun.
, vol.39
, pp. 1072-1079
-
-
Cryz Jr., S.J.1
Furer, E.2
Germanier, R.3
-
5
-
-
0031063093
-
-
Behring Inst. Mitt
-
Cryz, S. J., Jr., A. Lang, A. Rudeberg, J. Wedgwood, J. U. Que, E. Furer, and U. Schaad. 1997. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Behring Inst. Mitt:345-349.
-
(1997)
Immunization of Cystic Fibrosis Patients with a Pseudomonas Aeruginosa O-polysaccharide-toxin a Conjugate Vaccine
, pp. 345-349
-
-
Cryz Jr., S.J.1
Lang, A.2
Rudeberg, A.3
Wedgwood, J.4
Que, J.U.5
Furer, E.6
Schaad, U.7
-
6
-
-
0023267602
-
Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin a conjugates
-
Cryz, S. J., Jr., A. B. Lang, J. C. Sadoff, R. Germanier, and E. Furer. 1987. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates. Infect. Immun. 55:1547-1551.
-
(1987)
Infect. Immun.
, vol.55
, pp. 1547-1551
-
-
Cryz Jr., S.J.1
Lang, A.B.2
Sadoff, J.C.3
Germanier, R.4
Furer, E.5
-
7
-
-
0018777674
-
In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains
-
Desgranges, C., M. F. Lavoue, J. Patet, and G. de-The. 1979. In vitro transforming activity of Epstein-Barr virus (EBV). II. Differences between M81 and B95-8 EBV strains. Biomedicine 30:102-108.
-
(1979)
Biomedicine
, vol.30
, pp. 102-108
-
-
Desgranges, C.1
Lavoue, M.F.2
Patet, J.3
De-The, G.4
-
8
-
-
39149111898
-
Vaccines and immunotherapy against Pseudomonas aeruginosa
-
Doring, G., and G. B. Pier. 2008. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 26:1011-1024.
-
(2008)
Vaccine
, vol.26
, pp. 1011-1024
-
-
Doring, G.1
Pier, G.B.2
-
9
-
-
0345257052
-
Ventilator-associated pneumonia: Caveats for benchmarking
-
Eggimann, P., S. Hugonnet, H. Sax, S. Touveneau, J. C. Chevrolet, and D. Pittet. 2003. Ventilator-associated pneumonia: caveats for benchmarking. Intensive Care Med. 29:2086-2089.
-
(2003)
Intensive Care Med.
, vol.29
, pp. 2086-2089
-
-
Eggimann, P.1
Hugonnet, S.2
Sax, H.3
Touveneau, S.4
Chevrolet, J.C.5
Pittet, D.6
-
10
-
-
0035680987
-
Infection control in the ICU
-
Eggimann, P., and D. Pittet. 2001. Infection control in the ICU. Chest 120:2059-2093.
-
(2001)
Chest
, vol.120
, pp. 2059-2093
-
-
Eggimann, P.1
Pittet, D.2
-
11
-
-
0015263647
-
Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease
-
Falk, G. A., A. J. Okinaka, and G. W. Siskind. 1972. Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 105:14-21.
-
(1972)
Am. Rev. Respir. Dis.
, vol.105
, pp. 14-21
-
-
Falk, G.A.1
Okinaka, A.J.2
Siskind, G.W.3
-
12
-
-
0030692764
-
Pharmacokinetics, tolerability, and preliminary efficacy of human anti-Pseudomonas aeruginosa monoclonal antibodies in pneumonia and burn infection patients
-
Harrison, F. J., D. Rohm, T. Kohzuki, and H. Noguchi. 1997. Pharmacokinetics, tolerability, and preliminary efficacy of human anti-Pseudomonas aeruginosa monoclonal antibodies in pneumonia and burn infection patients. Hybridoma 16:413-420.
-
(1997)
Hybridoma
, vol.16
, pp. 413-420
-
-
Harrison, F.J.1
Rohm, D.2
Kohzuki, T.3
Noguchi, H.4
-
13
-
-
0032434029
-
Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies
-
Jansen, W. T., J. Gootjes, M. Zelle, D. V. Madore, J. Verhoef, H. Snippe, and A. F. Verheul. 1998. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies. Clin. Diagn. Lab. Immunol. 5:703-710.
-
(1998)
Clin. Diagn. Lab. Immunol.
, vol.5
, pp. 703-710
-
-
Jansen, W.T.1
Gootjes, J.2
Zelle, M.3
Madore, D.V.4
Verhoef, J.5
Snippe, H.6
Verheul, A.F.7
-
15
-
-
0025078706
-
Polysaccharide antigens of Pseudomonas aeruginosa
-
Knirel, Y. A. 1990. Polysaccharide antigens of Pseudomonas aeruginosa. Crit. Rev. Microbiol. 17:273-304.
-
(1990)
Crit. Rev. Microbiol.
, vol.17
, pp. 273-304
-
-
Knirel, Y.A.1
-
16
-
-
0028788729
-
The effect of late-onset ventilator-associated pneumonia in determining patient mortality
-
Kollef, M. H., P. Silver, D. M. Murphy, and E. Trovillion. 1995. The effect of late-onset ventilator-associated pneumonia in determining patient mortality. Chest 108:1655-1662.
-
(1995)
Chest
, vol.108
, pp. 1655-1662
-
-
Kollef, M.H.1
Silver, P.2
Murphy, D.M.3
Trovillion, E.4
-
17
-
-
0021721095
-
A human hybrid myeloma for production of human monoclonal antibodies
-
Kozbor, D., P. Tripputi, J. C. Roder, and C. M. Croce. 1984. A human hybrid myeloma for production of human monoclonal antibodies. J. Immunol. 133: 3001-3005. (Pubitemid 15216494)
-
(1984)
Journal of Immunology
, vol.133
, Issue.6
, pp. 3001-3005
-
-
Kozbor, D.1
Tripputi, P.2
Roder, J.C.3
Croce, C.M.4
-
18
-
-
0028051537
-
Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat
-
Landsperger, W. J., K. D. Kelly-Wintenberg, T. C. Montie, L. S. Knight, M. B. Hansen, C. C. Huntenburg, and M. J. Schneidkraut. 1994. Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. Infect. Immun. 62:4825-4830.
-
(1994)
Infect. Immun.
, vol.62
, pp. 4825-4830
-
-
Landsperger, W.J.1
Kelly-Wintenberg, K.D.2
Montie, T.C.3
Knight, L.S.4
Hansen, M.B.5
Huntenburg, C.C.6
Schneidkraut, M.J.7
-
19
-
-
0025646578
-
Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization
-
Lang, A. B., E. Furer, G. Senyk, J. W. Larrick, and S. J. Cryz, Jr. 1990. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Hum. Antibodies Hybridomas 1:96-103.
-
(1990)
Hum. Antibodies Hybridomas
, vol.1
, pp. 96-103
-
-
Lang, A.B.1
Furer, E.2
Senyk, G.3
Larrick, J.W.4
Cryz Jr., S.J.5
-
20
-
-
3042638668
-
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection
-
Lang, A. B., A. Rudeberg, M. H. Schoni, J. U. Que, E. Furer, and U. B. Schaad. 2004. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr. Infect. Dis. J. 23:504-510.
-
(2004)
Pediatr. Infect. Dis. J.
, vol.23
, pp. 504-510
-
-
Lang, A.B.1
Rudeberg, A.2
Schoni, M.H.3
Que, J.U.4
Furer, E.5
Schaad, U.B.6
-
21
-
-
0028862352
-
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
-
Lang, A. B., U. B. Schaad, A. Rudeberg, J. Wedgwood, J. U. Que, E. Furer, and S. J. Cryz, Jr. 1995. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J. Pediatr. 127:711-717.
-
(1995)
J. Pediatr.
, vol.127
, pp. 711-717
-
-
Lang, A.B.1
Schaad, U.B.2
Rudeberg, A.3
Wedgwood, J.4
Que, J.U.5
Furer, E.6
Cryz Jr., S.J.7
-
22
-
-
0026783618
-
Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium
-
Lang, A. B., U. Schurch, F. Zimmermann, and U. Bruderer. 1992. Selective generation of antigen-specific human hybridomas optimized for large scale growth in serum-free medium. J. Immunol. Methods 154:21-26.
-
(1992)
J. Immunol. Methods
, vol.154
, pp. 21-26
-
-
Lang, A.B.1
Schurch, U.2
Zimmermann, F.3
Bruderer, U.4
-
23
-
-
67749124368
-
Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers
-
Lazar, H., M. P. Horn, A. W. Zuercher, M. A. Imboden, P. Durrer, M. Seiberling, R. Pokorny, C. Hammer, and A. B. Lang. 2009. Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers. Antimicrob. Agents Chemother. 53:3442-3446.
-
(2009)
Antimicrob. Agents Chemother.
, vol.53
, pp. 3442-3446
-
-
Lazar, H.1
Horn, M.P.2
Zuercher, A.W.3
Imboden, M.A.4
Durrer, P.5
Seiberling, M.6
Pokorny, R.7
Hammer, C.8
Lang, A.B.9
-
24
-
-
0032798037
-
A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine
-
Martinez, J. E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G. M. Carlone. 1999. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
-
(1999)
Clin. Diagn. Lab. Immunol.
, vol.6
, pp. 581-586
-
-
Martinez, J.E.1
Romero-Steiner, S.2
Pilishvili, T.3
Barnard, S.4
Schinsky, J.5
Goldblatt, D.6
Carlone, G.M.7
-
25
-
-
0032807421
-
Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice
-
Matsumoto, T., K. Tateda, S. Miyazaki, N. Furuya, A. Ohno, Y. Ishii, Y. Hirakata, and K. Yamaguchi. 1999. Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice. Clin. Diagn. Lab. Immunol. 6:537-541.
-
(1999)
Clin. Diagn. Lab. Immunol.
, vol.6
, pp. 537-541
-
-
Matsumoto, T.1
Tateda, K.2
Miyazaki, S.3
Furuya, N.4
Ohno, A.5
Ishii, Y.6
Hirakata, Y.7
Yamaguchi, K.8
-
26
-
-
0028557981
-
Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial
-
McCloskey, R. V., R. C. Straube, C. Sanders, S. M. Smith, C. R. Smith, et al. 1994. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 121:1-5.
-
(1994)
Ann. Intern. Med.
, vol.121
, pp. 1-5
-
-
McCloskey, R.V.1
Straube, R.C.2
Sanders, C.3
Smith, S.M.4
Smith, C.R.5
-
27
-
-
0027393911
-
Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients
-
Meng, Y. G., T. Wong, L. D. Saravolatz, and J. E. Pennington. 1993. Pharmacokinetics of an IgM human monoclonal antibody against Pseudomonas aeruginosa in nonseptic patients. J. Infect. Dis. 167:784-785.
-
(1993)
J. Infect. Dis.
, vol.167
, pp. 784-785
-
-
Meng, Y.G.1
Wong, T.2
Saravolatz, L.D.3
Pennington, J.E.4
-
28
-
-
11244299890
-
Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital
-
Muller-Premru, M., and M. Gubina. 2000. Serotype, antimicrobial susceptibility and clone distribution of Pseudomonas aeruginosa in a university hospital. Zentralbl. Bakteriol. 289:857-867.
-
(2000)
Zentralbl. Bakteriol.
, vol.289
, pp. 857-867
-
-
Muller-Premru, M.1
Gubina, M.2
-
29
-
-
40649127250
-
Anti-infective antibodies: A novel tool to prevent and treat nosocomial diseases
-
Nagy, E., C. Giefing, and A. von Gabain. 2008. Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases. Expert Rev. Anti-Infect. Ther. 6:21-30.
-
(2008)
Expert Rev. Anti-Infect. Ther.
, vol.6
, pp. 21-30
-
-
Nagy, E.1
Giefing, C.2
Von Gabain, A.3
-
30
-
-
0025968886
-
Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa
-
Ochi, H., H. Ohtsuka, S. Yokota, I. Uezumi, M. Terashima, K. Irie, and H. Noguchi. 1991. Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa. Infect. Immun. 59:550-554.
-
(1991)
Infect. Immun.
, vol.59
, pp. 550-554
-
-
Ochi, H.1
Ohtsuka, H.2
Yokota, S.3
Uezumi, I.4
Terashima, M.5
Irie, K.6
Noguchi, H.7
-
31
-
-
34547531757
-
Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation, and target for effective immunity
-
Pier, G. B. 2007. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation, and target for effective immunity. Int. J. Med. Microbiol. 297:277-295.
-
(2007)
Int. J. Med. Microbiol.
, vol.297
, pp. 277-295
-
-
Pier, G.B.1
-
32
-
-
0036283567
-
Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa
-
Raymond, C. K., E. H. Sims, A. Kas, D. H. Spencer, T. V. Kutyavin, R. G. Ivey, Y. Zhou, R. Kaul, J. B. Clendenning, and M. V. Olson. 2002. Genetic variation at the O-antigen biosynthetic locus in Pseudomonas aeruginosa. J. Bacteriol. 184:3614-3622.
-
(2002)
J. Bacteriol.
, vol.184
, pp. 3614-3622
-
-
Raymond, C.K.1
Sims, E.H.2
Kas, A.3
Spencer, D.H.4
Kutyavin, T.V.5
Ivey, R.G.6
Zhou, Y.7
Kaul, R.8
Clendenning, J.B.9
Olson, M.V.10
-
33
-
-
33644782751
-
Anti-infective monoclonal antibodies: Perils and promise of development
-
Reichert, J. M., and M. C. Dewitz. 2006. Anti-infective monoclonal antibodies: perils and promise of development. Nat. Rev. Drug Discov. 5:191-195.
-
(2006)
Nat. Rev. Drug Discov.
, vol.5
, pp. 191-195
-
-
Reichert, J.M.1
Dewitz, M.C.2
-
34
-
-
0016120684
-
Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage
-
Reynolds, H. Y., and H. H. Newball. 1974. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J. Lab. Clin. Med. 84:559-573.
-
(1974)
J. Lab. Clin. Med.
, vol.84
, pp. 559-573
-
-
Reynolds, H.Y.1
Newball, H.H.2
-
35
-
-
0015694635
-
Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa
-
Reynolds, H. Y., and R. E. Thompson. 1973. Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa. J. Immunol. 111:358-368.
-
(1973)
J. Immunol.
, vol.111
, pp. 358-368
-
-
Reynolds, H.Y.1
Thompson, R.E.2
-
37
-
-
55049094675
-
International Nosocomial Infection Control Consortium report, data summary for 2002-2007
-
issued January 2008
-
Rosenthal, V. D., D. G. Maki, A. Mehta, C. Alvarez-Moreno, H. Leblebicioglu, F. Higuera, L. E. Cuellar, N. Madani, Z. Mitrev, L. Duenas, J. A. Navoa-Ng, H. G. Garcell, L. Raka, R. F. Hidalgo, E. A. Medeiros, S. S. Kanj, S. Abubakar, P. Nercelles, and R. D. Pratesi. 2008. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am. J. Infect. Control 36:627-637.
-
(2008)
Am. J. Infect. Control
, vol.36
, pp. 627-637
-
-
Rosenthal, V.D.1
Maki, D.G.2
Mehta, A.3
Alvarez-Moreno, C.4
Leblebicioglu, H.5
Higuera, F.6
Cuellar, L.E.7
Madani, N.8
Mitrev, Z.9
Duenas, L.10
Navoa-Ng, J.A.11
Garcell, H.G.12
Raka, L.13
Hidalgo, R.F.14
Medeiros, E.A.15
Kanj, S.S.16
Abubakar, S.17
Nercelles, P.18
Pratesi, R.D.19
-
38
-
-
0026095292
-
Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients
-
Saravolatz, L. D., N. Markowitz, M. S. Collins, D. Bogdanoff, and J. E. Pennington. 1991. Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients. J. Infect. Dis. 164:803-806.
-
(1991)
J. Infect. Dis.
, vol.164
, pp. 803-806
-
-
Saravolatz, L.D.1
Markowitz, N.2
Collins, M.S.3
Bogdanoff, D.4
Pennington, J.E.5
-
39
-
-
0023549786
-
Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa
-
Sawada, S., T. Kawamura, and Y. Masuho. 1987. Immunoprotective human monoclonal antibodies against five major serotypes of Pseudomonas aeruginosa. J. Gen. Microbiol. 133:3581-3590.
-
(1987)
J. Gen. Microbiol.
, vol.133
, pp. 3581-3590
-
-
Sawada, S.1
Kawamura, T.2
Masuho, Y.3
-
40
-
-
0025950064
-
Safety and immunogenicity of Pseudomonas aeruginosa conjugate a vaccine in cystic fibrosis
-
Schaad, U. B., A. B. Lang, J. Wedgwood, A. Ruedeberg, J. U. Que, E. Furer, and S. J. Cryz, Jr. 1991. Safety and immunogenicity of Pseudomonas aeruginosa conjugate A vaccine in cystic fibrosis. Lancet 338:1236-1237.
-
(1991)
Lancet
, vol.338
, pp. 1236-1237
-
-
Schaad, U.B.1
Lang, A.B.2
Wedgwood, J.3
Ruedeberg, A.4
Que, J.U.5
Furer, E.6
Cryz Jr., S.J.7
-
41
-
-
0029941969
-
Generation and characterization of a human monoclonal IgM antibody that recognizes a conserved epitope shared by lipopolysaccharides of different gram-negative bacteria
-
Seifert, M., G. Schoenherr, D. Roggenbuck, U. Marx, and R. von Baehr. 1996. Generation and characterization of a human monoclonal IgM antibody that recognizes a conserved epitope shared by lipopolysaccharides of different gram-negative bacteria. Hybridoma 15:191-198. (Pubitemid 26240435)
-
(1996)
Hybridoma
, vol.15
, Issue.3
, pp. 191-198
-
-
Seifert, M.1
Schoenherr, G.2
Roggenbuck, D.3
Marx, U.4
Von Baehr, R.5
-
42
-
-
33947227044
-
Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan
-
Sekiguchi, J., T. Asagi, T. Miyoshi-Akiyama, A. Kasai, Y. Mizuguchi, M. Araake, T. Fujino, H. Kikuchi, S. Sasaki, H. Watari, T. Kojima, H. Miki, K. Kanemitsu, H. Kunishima, Y. Kikuchi, M. Kaku, H. Yoshikura, T. Kuratsuji, and T. Kirikae. 2007. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J. Clin. Microbiol. 45:979-989.
-
(2007)
J. Clin. Microbiol.
, vol.45
, pp. 979-989
-
-
Sekiguchi, J.1
Asagi, T.2
Miyoshi-Akiyama, T.3
Kasai, A.4
Mizuguchi, Y.5
Araake, M.6
Fujino, T.7
Kikuchi, H.8
Sasaki, S.9
Watari, H.10
Kojima, T.11
Miki, H.12
Kanemitsu, K.13
Kunishima, H.14
Kikuchi, Y.15
Kaku, M.16
Yoshikura, H.17
Kuratsuji, T.18
Kirikae, T.19
-
43
-
-
0031772804
-
Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia
-
Song, Z., A. Kharazmi, H. Wu, V. Faber, C. Moser, H. K. Krogh, J. Rygaard, and N. Hoiby. 1998. Effects of ginseng treatment on neutrophil chemiluminescence and immunoglobulin G subclasses in a rat model of chronic Pseudomonas aeruginosa pneumonia. Clin. Diagn. Lab. Immunol. 5:882-887.
-
(1998)
Clin. Diagn. Lab. Immunol.
, vol.5
, pp. 882-887
-
-
Song, Z.1
Kharazmi, A.2
Wu, H.3
Faber, V.4
Moser, C.5
Krogh, H.K.6
Rygaard, J.7
Hoiby, N.8
-
44
-
-
0024805809
-
Biological role of different antibody classes
-
Spiegelberg, H. L. 1989. Biological role of different antibody classes. Int. Arch. Allergy Appl. Immunol. 90(Suppl. 1):22-27.
-
(1989)
Int. Arch. Allergy Appl. Immunol.
, vol.90
, Issue.SUPPL. 1
, pp. 22-27
-
-
Spiegelberg, H.L.1
-
45
-
-
36549038193
-
Monoclonal antibodies for prophylaxis and therapy of infectious diseases
-
ter Meulen, J. 2007. Monoclonal antibodies for prophylaxis and therapy of infectious diseases. Expert Opin. Emerg. Drugs 12:525-540.
-
(2007)
Expert Opin. Emerg. Drugs
, vol.12
, pp. 525-540
-
-
Ter Meulen, J.1
-
46
-
-
33745112513
-
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis
-
Zuercher, A. W., M. P. Horn, J. U. Que, A. Ruedeberg, M. H. Schoeni, U. B. Schaad, P. Marcus, and A. B. Lang. 2006. Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis. FEMS Immunol. Med. Microbiol. 47: 302-308.
-
(2006)
FEMS Immunol. Med. Microbiol.
, vol.47
, pp. 302-308
-
-
Zuercher, A.W.1
Horn, M.P.2
Que, J.U.3
Ruedeberg, A.4
Schoeni, M.H.5
Schaad, U.B.6
Marcus, P.7
Lang, A.B.8
-
47
-
-
0023676805
-
Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa
-
Zweerink, H. J., M. C. Gammon, C. F. Hutchison, J. J. Jackson, D. Lombardo, K. M. Miner, J. M. Puckett, T. J. Sewell, and N. H. Sigal. 1988. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa. Infect. Immun. 56:1873-1879.
-
(1988)
Infect. Immun.
, vol.56
, pp. 1873-1879
-
-
Zweerink, H.J.1
Gammon, M.C.2
Hutchison, C.F.3
Jackson, J.J.4
Lombardo, D.5
Miner, K.M.6
Puckett, J.M.7
Sewell, T.J.8
Sigal, N.H.9
-
48
-
-
0023876799
-
X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa
-
Zweerink, H. J., M. C. Gammon, C. F. Hutchison, J. J. Jackson, G. B. Pier, J. M. Puckett, T. J. Sewell, and N. H. Sigal. 1988. X-linked immunodeficient mice as a model for testing the protective efficacy of monoclonal antibodies against Pseudomonas aeruginosa. Infect. Immun. 56:1209-1214.
-
(1988)
Infect. Immun.
, vol.56
, pp. 1209-1214
-
-
Zweerink, H.J.1
Gammon, M.C.2
Hutchison, C.F.3
Jackson, J.J.4
Pier, G.B.5
Puckett, J.M.6
Sewell, T.J.7
Sigal, N.H.8
|